Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
856.00    -3.00 (-0.35%)
Bid:
855.00
Ask:
864.00
Spread: 9.00 (1.053%)
Market Cap: £807.63m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

13 Apr 2026 07:00

RNS Number : 0699A
Polar Capital Holdings PLC
13 April 2026
 

13 April 2026 Polar Capital Holdings plc

AuM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides its regular quarterly update of its unaudited statement of Assets under Management ("AuM") for the financial year to 31 March 2026.

 

Group AuM (unaudited)

 

Polar Capital reports that as at 31 March 2026 its AuM was £30.6bn compared to £28.4bn at the end of December 2025, an increase of 8% over the quarter. In the quarter, AuM increased by net inflows of £1.4bn, fund performance and market movements of £0.8bn, offset by fund closures of £13m.

 

AuM movement in three months to 31 March 2026

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated mandates

(£m)

Total

(£m)

AuM at 1 January 2026

21,366

 

6,482

539

28,387

Net flows

 1,386

 (5)

62

1,443

Fund closures1

(13)

-

-

(13)

Market movement

and performance

685

128

3

816

Total AuM at 31 March 2026

23,424

6,605

604

30,633

 

 

 

AuM movement in twelve months to 31 March 2026

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated mandates

(£m)

Total

(£m)

AuM at 1 April 2025

15,994

4,846

569

21,409

Net flows

 1,233

 (237)

 (94)

 902

Corporate actions2

-

 (396)

-

(396)

Fund closures1

 (75)

-

-

 (75)

Market movement

and performance

 6,272

 2,392

 129

 8,793

Total AuM at 31 March 2026

23,424

6,605

604

30,633

1 Return of funds to investors upon the closure of the Polar Capital Emerging Market ex-China Stars Fund in February 2026, Polar Capital China Stars Fund in January 2026 and the Polar Capital Melchior European Opportunities Fund in November 2025.

2 Return of capital to investors in June 2025 as the Polar Capital Global Financials Trust underwent a 100% tender offer following which 44% of issued capital was tendered and in November 2025 when Polar Capital Global Healthcare Trust underwent a 100% tender offer following which 22% of issued capital was tendered.

 

 

Iain Evans, Chief Executive, commented:

"We have delivered a strong finish to the financial year, despite a backdrop of heightened geopolitical uncertainty and ongoing market volatility. Over the quarter, assets under management (AuM) increased by 8% to £30.6bn, up from £28.4bn at the end of December, supported by net inflows of £1.4bn.

 

"For the full financial year, AuM increased by 43% to £30.6bn, from £21.4bn at the end of March 2025, reflecting a combination of net inflows, fund performance and market movements. We delivered a second consecutive year of positive net inflows, totalling £902m (excluding corporate actions and fund closures), demonstrating the strength of our specialist investment capabilities.

 

"Flows during the quarter were broad-based, with several of our investment teams generating net inflows, led by Technology, Healthcare and Smart Energy. Net flows into our Global Technology (£722m) and Artificial Intelligence (£575m) funds remained particularly strong, driven by continued client interest in structural growth opportunities and supported by both increased allocations from existing clients and new client wins, notably across wealth and private bank channels in Europe and Asia.

 

"Our Healthcare strategies also contributed positively, including the launch of a new separately managed account in partnership with a Swiss wealth manager. In addition, Emerging Market Stars, Japan Value and Global Absolute Return funds each delivered net inflows, further highlighting the breadth of our platform.

 

"Net outflows were largely concentrated in North American (£97m), Global Insurance (£85m) and Asian Stars (£55m) funds, reflecting a small number of client-specific redemptions rather than any broader shift in demand or sentiment.

 

Outlook

"We have entered 2026 with positive net inflow momentum, although we remain mindful of the structural challenges facing the industry. Inflows were strongest in January and February, before moderating in March following the escalation of conflict in the Middle East. Encouragingly, positive momentum has continued into April to date.

"The geopolitical backdrop has become more uncertain, contributing to heightened market sensitivity, particularly in energy markets. Despite this, we remain confident in our positioning as a specialist boutique. As markets broaden and the pace of technological disruption, including AI, accelerates, the case for specialist active management is becoming increasingly compelling. Our focus on differentiated capabilities, deep expertise and disciplined execution positions us well to navigate the uncertainty and capture opportunities ahead for our clients and shareholders."

 

Polar Capital plans to announce its results for the financial year ended 31 March 2026 on 1 July 2026.

 

 

For further information please contact:

 

Polar Capital

Iain Evans (Chief Executive)

Samir Ayub (Chief Financial Officer)

 

+44 (0)20 7227 2700

 

Deutsche Numis - - Nomad and Joint Broker

Charles Farquhar

Duncan Monteith

Rajesh Iyer

 

+44 (0)20 7260 1000

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Thomas Philpott

 

+44 (0)20 3597 8680

 

 

Camarco - PR

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

+44 (0)20 3757 4980

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAKLEFDFKEFA
Date   Source Headline
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results
19th Oct 20222:52 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSAuM Update
29th Sep 202210:33 amRNSHolding(s) in Company
7th Sep 20224:18 pmRNSResult of AGM
31st Aug 20222:03 pmRNSForm 8.3 - Diurnal Group PLC
26th Aug 20229:20 amRNSHolding(s) in Company
1st Aug 20227:00 amRNSBlock listing Interim Review
21st Jul 202212:14 pmRNSDirector/PDMR Shareholding - Replacement
20th Jul 202210:57 amRNSDirector/PDMR Shareholding
20th Jul 202210:26 amRNSDirector/PDMR Shareholding
14th Jul 20224:11 pmRNSHolding(s) in Company
14th Jul 20227:00 amRNSAuM Update
13th Jul 20223:25 pmRNSForm 8.3 - Serica Energy PLC
13th Jul 202210:23 amRNSDirector/PDMR Shareholding
6th Jul 20225:50 pmRNSDirector/PDMR Shareholding
29th Jun 20221:10 pmRNSHolding(s) in Company
27th Jun 20227:00 amRNSGroup Audited Results for year ended 31 March 2022
21st Jun 20227:00 amRNSInvestor Presentation covering Preliminary Results
15th Jun 202210:59 amRNSHolding(s) in Company
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202210:01 amRNSIssue of Equity
26th May 20227:00 amRNSNotice of Results
16th May 20224:26 pmRNSHolding(s) in Company
6th May 20224:55 pmRNSDirector/PDMR Shareholding
4th May 202212:15 pmRNSDirector/PDMR Shareholding
28th Apr 20222:38 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSAuM Update
12th Apr 20227:00 amRNSFund Terminations
11th Apr 20225:03 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.